Rational N-Terminal Tuning of Bacitracin A: Repurposing a Classic Antibiotic to Combat Multidrug-Resistant Gram-Positive Pathogens
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Sijie Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong264117, China. Hauptthemen laut MEDLINE: Bacitracin, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Drug Repositioning. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, Bohai Rim Advanced Research Institute for Drug Discovery, Shandong Laboratory of Yantai Drug Discovery.
Abstract (Originalsprache)
The increasing threat of infections caused by multidrug-resistant Gram-positive pathogens such as MRSA and VRE has driven the structural remodeling and repurposing of traditional antibiotics as a key strategy to combat bacterial resistance. Herein, using bacitracin A as a lead template, we established a site-selective semisynthetic modification strategy via reductive amination of its N-terminal primary amine. 32 derivatives were designed and synthesized, and their structure–activity relationships were systematically evaluated. Optimized derivatives exhibited potent activity against MRSA and VRE, with 4–32-fold enhanced antibacterial potency compared with bacitracin A, together with improved bactericidal properties, safety profiles, and pharmacokinetic characteristics. Mechanistically, hydrophobic N-terminal modification endows bacitracin A with multiple antibacterial modes, including enhanced inhibition of cell wall peptidoglycan biosynthesis, obvious membrane depolarization, and disruption of the purine metabolic pathway. These findings provide a rational strategy for bacitracin optimization and highlight the potential of N-terminal modification for developing improved antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong264117, China.
- Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, School of Pharmacy, Yantai University, Yantai, Shandong264005, China.
- National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing400038, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences , No. 555 Zuchongzhi Rd, Pudong, Shanghai201203, China.
- University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing100049, China.
ORCID-Profile: Yanping Zhu, Dongliang Guan
Förderung
- Key Technology Research and Development Program of Shandong Province
- Bohai Rim Advanced Research Institute for Drug Discovery
- Shandong Laboratory of Yantai Drug Discovery
Zitieren
APA
Cheng, S., Liao, J., Xia, X., Chen, Z., Zhu, Y., Li, F., Zhang, J., & Guan, D. (2026). Rational N-Terminal Tuning of Bacitracin A: Repurposing a Classic Antibiotic to Combat Multidrug-Resistant Gram-Positive Pathogens. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01544
Vancouver
Cheng S, Liao J, Xia X, Chen Z, Zhu Y, Li F, et al. Rational N-Terminal Tuning of Bacitracin A: Repurposing a Classic Antibiotic to Combat Multidrug-Resistant Gram-Positive Pathogens. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01544
BibTeX
@article{Cheng2026,
author = {Cheng, Sijie and Liao, Jingwen and Xia, Xinru and Chen, Zhifu and Zhu, Yanping and Li, Fang and Zhang, Jinyong and Guan, Dongliang},
title = {Rational N-Terminal Tuning of Bacitracin A: Repurposing a Classic Antibiotic to Combat Multidrug-Resistant Gram-Positive Pathogens},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01544}
}
EUVIMED